Internal Medicine, Hematology & Oncology · Gettysburg, PA
NPI
1730338112
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
20 Expedition Trl, Suite 101
Gettysburg, PA, 17325
Phone (717) 334-4033
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.5M
168,868 services
Medicare patients, 2024
539
Average age 76
Drug cost, 2024
$8.5M
1,905 prescriptions
Company payments, 2025
$627
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tina A Khair was code J1756 (injection, iron sucrose, 1 mg), 13,000 times for 11 patients. In total Tina A Khair billed 168,868 services in 131 codes, and Medicare paid $3.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-02-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1756 Injection, iron sucrose, 1 mg | Office | 13,000 | 11 | $0.17 | $2,217 |
| J0897 Injection, denosumab, 1 mg | Office | 7,787 | 41 | $20.30 | $158K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 6,800 | 49 | $15.55 | $106K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 4,714 | 42 | $0.09 | $416 |
| 85025 Blood Count | Office | 2,285 | 461 | $7.58 | $17K |
| 36415 Venipuncture Blood Collection | Office | 2,154 | 469 | $8.62 | $19K |
| 99214 Office E&M - Established | Office | 1,550 | 391 | $99.35 | $154K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,310 | 23 | $0.69 | $906 |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 825 | 15 | $5.54 | $4,575 |
| 96367 Intravenous Infusion, Hydration | Office | 433 | 64 | $22.54 | $9,761 |
| 96413 Chemotherapy Administration | Office | 404 | 55 | $100.35 | $41K |
| 96372 Injection Administration | Office | 404 | 84 | $10.97 | $4,433 |
| 96365 Intravenous Infusion, Hydration | Office | 386 | 98 | $48.75 | $19K |
| 96401 Chemotherapy Administration | Office | 369 | 20 | $55.83 | $21K |
| Q5108 Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg | Office | 362 | 12 | $114.03 | $41K |
By year: 2022 $2.8M for 171,685 services; 2023 $3.3M for 170,561 services; 2024 $3.5M for 168,868 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,285 | 461 | $7.58 | $17K |
| 36415 Venipuncture Blood Collection | 2,154 | 469 | $8.62 | $19K |
Medicare prescription drug claims, 2024
In 2024, the drug Tina A Khair prescribed most often to Medicare patients was Letrozole, with 156 prescriptions and refills. In total Tina A Khair wrote 1,905 Medicare prescriptions that cost $8.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 156 | 397 | 48 | $3,418 |
| Xgeva Denosumab | 108 | 114 | 12 | $336K |
| Procrit Epoetin Alfa | 65 | 65 | 18 | $231K |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 65 | 65 | Under 11 | $679K |
| Ondansetron Hcl Generic | 58 | 58 | 33 | $675 |
| Anastrozole Generic | 57 | 156 | 18 | $1,414 |
| Hydroxyurea Generic | 55 | 92 | 12 | $1,278 |
| Lenalidomide Generic | 55 | 55 | Under 11 | $804K |
| Keytruda Pembrolizumab | 54 | 54 | Under 11 | $603K |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 52 | 57 | Under 11 | $425K |
| Prochlorperazine Maleate Generic | 44 | 44 | 29 | $480 |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 39 | 39 | Under 11 | $234K |
| Prednisone Generic | 38 | 44 | Under 11 | $176 |
| Exemestane Generic | 36 | 92 | Under 11 | $5,748 |
| Fulvestrant Generic | 36 | 36 | Under 11 | $43K |
Brand drugs: 958 claims; generic drugs: 947 claims; opioid claims: 34.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tina A Khair $627 ($627 in general payments such as food, travel and fees) from 18 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $102.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 2 | $102 |
| Eisai Inc. 4523.T | 2 | $54.82 |
| Janssen Biotech, Inc. JNJ | 2 | $53.34 |
| PharmaEssentia USA Corporation 6446.TW | 2 | $49.93 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $44.97 |
| BeOne Medicines USA, Inc. ONC | 1 | $33.01 |
| Merck Sharp & Dohme LLC MRK | 1 | $30.56 |
| TerSera Therapeutics LLC | 1 | $27.96 |
| Incyte Corporation INCY | 1 | $27.83 |
| Avyxa Pharma, LLC | 1 | $26.67 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.